New Delhi, September 15:
Sputnik’s single-dose Covid-19 vaccine, Sputnik Light, has received the approval of the Drugs Controller General of India (DCGI) to conduct phase III bridging trials on the Indian population.
New Delhi, September 15:
Sputnik’s single-dose Covid-19 vaccine, Sputnik Light, has received the approval of the Drugs Controller General of India (DCGI) to conduct phase III bridging trials on the Indian population.